Farallon Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $145,928 - $240,004	5,800 New	5,800 $206,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $7.05 Million - $12.4 Million	-177,917 Reduced 55.49%	142,700 $6.56 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $27.6 Million - $39.3 Million	-475,961 Reduced 59.75%	320,617 $21.3 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $25.2 Million - $36.7 Million	431,578 Added 118.24%	796,578 $49.7 Million
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $12 Million - $17.4 Million	192,546 Added 111.65%	365,000 $30.2 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $6.43 Million - $9.49 Million	104,854 Added 155.11%	172,454 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $15.6 Million - $30.4 Million	-356,000 Reduced 84.04%	67,600 $5.19 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $12.5 Million - $19.3 Million	-376,400 Reduced 47.05%	423,600 $18.2 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $5.22 Million - $8.65 Million	-200,000 Reduced 20.0%	800,000 $34.6 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $18.5 Million - $56.8 Million	900,000 Added 900.0%	1,000,000 $28.8 Million
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $15.5 Million - $40.2 Million	-550,000 Reduced 84.62%	100,000 $6.34 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $35.5 Million - $47.1 Million	-1,350,000 Reduced 67.5%	650,000 $18.3 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $1.38 Million - $2.29 Million	79,391 Added 4.13%	2,000,000 $53 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $5.07 Million - $8.49 Million	420,609 Added 28.04%	1,920,609 $35.2 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $16.1 Million - $29.6 Million	1,500,000 New	1,500,000 $18.6 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account